FASENRA SCEI for Long-term Use

CompletedOBSERVATIONAL
Enrollment

653

Participants

Timeline

Start Date

May 31, 2018

Primary Completion Date

September 10, 2024

Study Completion Date

September 10, 2024

Conditions
Asthma
Trial Locations (29)

D3250C00057

Research Site, Aichi

Research Site, Akita

Research Site, Aomori

Research Site, Chiba

Research Site, Ehime

Research Site, Fukuoka

Research Site, Gunma

Research Site, Hiroshima

Research Site, Hokkaido

Research Site, Hyōgo

Research Site, Ibaraki

Research Site, Kagawa

Research Site, Kagoshima

Research Site, Kanagawa

Research Site, Kumamoto

Research Site, Kyoto

Research Site, Mie

Research Site, Miyagi

Research Site, Numakunai

Research Site, Okayama

Research Site, Okinawa

Research Site, Osaka

Research Site, Ōita

Research Site, Saitama

Research Site, Shiga

Research Site, Tochigi

Research Site, Tokyo

Research Site, Yamagata

Research Site, Yamaguchi

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY